Strategies for Measuring the Quality of Psychotherapy: A White Paper to Inform Measure Development and Implementation. Appendix A. Clinical Guideline Definitions of Evidence Ratings

05/15/2014

Guideline Developer Term and Definition
American Psychiatric Association Substantial clinical confidence: Definition not provided in guideline. 

Moderate clinical confidence: Definition not provided in guideline. 

Guideline Workgroup and Guideline Steering Committee: The guideline was developed by a work group and under the direction of a steering committee.

National Institute for Health and Clinical Excellence (for depression and anxiety) Very low: Any estimate of effect is uncertain. 

Low: Further research is very likely to have an important impact on our confidence in the estimate of the effect and is likely to change the estimate. 

Moderate: Further research is likely to have an important impact on our confidence in the estimate of the effect and may change the estimate. 

High: Further research is very unlikely to change our confidence in the estimate of the effect.

National Institute for Health and Clinical Excellence (for PTSD) Treatment shows clinically important benefits: At least one RCT as part of a body of literature of overall good quality and consistency addressing the specific recommendation without extrapolation. 

Good practice point: Based on the clinical experience of the guideline development group.

U.S. Department of Veteran Affairs/ U.S. Department of Defense Strong recommendation to provide the treatment: Good evidence was found that the intervention improves important health outcomes and concludes that benefits substantially outweigh harm. 

No recommendation for or against the routine provision of the treatment: At least fair evidence was found that the intervention can improve health outcomes, but concludes that the balance of benefits and harms is too close to justify a general recommendation.

Australian Center for Post Traumatic Mental Health Body of evidence can be trusted to guide practice: Grade A rating; no further definition provided.
 

This report was prepared under contract #HHSP2332010016WI between the U.S. Department of Health and Human Services (HHS), Office of Disability, Aging and Long-Term Care Policy (DALTCP) and Mathematica Policy Research. For additional information about this subject, you can visit the DALTCP home page at http://aspe.hhs.gov/office_specific/daltcp.cfm or contact the ASPE Project Officer, D.E.B. Potter, at HHS/ASPE/DALTCP, Room 424E, H.H. Humphrey Building, 200 Independence Avenue, S.W., Washington, D.C. 20201. His e-mail address is: D.E.B.Potter@hhs.gov.

To obtain a printed copy of these reports, send the full report title and your mailing information to:

U.S. Department of Health and Human Services
Office of Disability, Aging and Long-Term Care Policy
Room 424E, H.H. Humphrey Building
200 Independence Avenue, S.W.
Washington, D.C. 20201
FAX:  202-401-7733
Email:  webmaster.DALTCP@hhs.gov

View full report

Preview
Download

"QualPsy.pdf" (pdf, 445.96Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®